{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:50:53Z","timestamp":1791607853179,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006591","name":"FibroGen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006591","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017009","name":"Bellerophon Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.chest.2020.02.016","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:23:56Z","timestamp":1582291436000},"page":"637-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of\u00a0Pulmonary Hypertension Associated With Pulmonary Fibrosis"],"prefix":"10.1016","volume":"158","author":[{"given":"Steven D.","family":"Nathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin.R.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn.K.","family":"Glassberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Raghu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Swigris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Ettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Loyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2020.02.016_bib1","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2020.02.016_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12931-014-0154-6","article-title":"Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia","volume":"15","author":"Moua","year":"2014","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.chest.2020.02.016_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1378\/chest.13-2388","article-title":"Pulmonary function and survival in idiopathic vs\u00a0secondary usual interstitial pneumonia","volume":"146","author":"Strand","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2020.02.016_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1378\/chest.10-2572","article-title":"Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium","volume":"140","author":"Nathan","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.chest.2020.02.016_bib5","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.rmed.2016.11.003","article-title":"Idiopathic interstitial pneumonia-associated pulmonary hypertension: a target for therapy?","volume":"122","author":"Nathan","year":"2017","journal-title":"Respir Med X"},{"issue":"9","key":"10.1016\/j.chest.2020.02.016_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1164\/rccm.200608-1153CC","article-title":"Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots","volume":"175","author":"Nathan","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2020.02.016_bib7","series-title":"A42: New Developments in ILD Research","article-title":"Unravelling the mode of action of pulsed inhaled nitric oxide in severe Ipf using functional respiratory imaging (fri)","author":"Hajian","year":"2017"},{"issue":"25","key":"10.1016\/j.chest.2020.02.016_bib8","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMra051884","article-title":"Inhaled nitric oxide therapy in adults","volume":"353","author":"Griffiths","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2020.02.016_bib9","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.83.6.2038","article-title":"Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction","volume":"83","author":"Frostell","year":"1991","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chest.2020.02.016_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1152\/japplphysiol.01104.2010","article-title":"Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis","volume":"110","author":"Blanco","year":"2010","journal-title":"J\u00a0Appl Physiol"},{"issue":"6","key":"10.1016\/j.chest.2020.02.016_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2020.02.016_bib12","first-page":"67","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2020.02.016_bib13","doi-asserted-by":"crossref","first-page":"e0154587","DOI":"10.1371\/journal.pone.0154587","article-title":"The minimal important difference in physical activity in patients with COPD","volume":"11","author":"Demeyer","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.chest.2020.02.016_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4236\/wjcd.2012.23021","article-title":"Analysis of daily activity data from implanted cardiac defibrillators: the minimum clinically important difference and relationship to mortality\/life expectancy","author":"Shoemaker","year":"2012","journal-title":"World J Cardiovasc Dis"},{"key":"10.1016\/j.chest.2020.02.016_bib15","first-page":"1","article-title":"Physical activity in COPD: minimal clinically important difference for medical events","volume":"16","author":"Teylan","year":"2018","journal-title":"Chronic Respir Dis"},{"issue":"3","key":"10.1016\/j.chest.2020.02.016_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.21693\/1933-088X-12.3.127","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"12","author":"Rivera-Lebron","year":"2013","journal-title":"Adv Pulm Hypertens"},{"key":"10.1016\/j.chest.2020.02.016_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2147\/DDDT.S64907","article-title":"Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?","volume":"8","author":"Nathan","year":"2014","journal-title":"Drug Des Dev Ther"},{"issue":"8","key":"10.1016\/j.chest.2020.02.016_bib18","first-page":"73","article-title":"Physical activity and exertional desaturation are associated with mortality in idiopathic pulmonary fibrosis","volume":"5","author":"Vainshelboim","year":"2016","journal-title":"J\u00a0Clin Med"},{"issue":"6","key":"10.1016\/j.chest.2020.02.016_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jval.2017.09.012","article-title":"Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium","volume":"21","author":"Byrom","year":"2018","journal-title":"Value in Health"},{"issue":"4","key":"10.1016\/j.chest.2020.02.016_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pcad.2014.09.008","article-title":"Physical activity versus cardiorespiratory fitness: two (partly) distinct components of cardiovascular health?","volume":"57","author":"DeFina","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.chest.2020.02.016_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.resinv.2017.09.004","article-title":"Physical activity in daily life in patients with idiopathic pulmonary fibrosis","volume":"56","author":"Nishiyama","year":"2018","journal-title":"Respir Investig"},{"key":"10.1016\/j.chest.2020.02.016_bib22","article-title":"Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis","volume":"104","author":"Bahmer","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"11","key":"10.1016\/j.chest.2020.02.016_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027993","article-title":"Assessment of daily life physical activities in pulmonary arterial hypertension","volume":"6","author":"Mainguy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.chest.2020.02.016_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gaitpost.2015.11.005","article-title":"Comparison of physical activity assessed using hip-and wrist-worn accelerometers","volume":"44","author":"Kamada","year":"2016","journal-title":"Gait Posture"},{"issue":"3","key":"10.1016\/j.chest.2020.02.016_bib25","first-page":"422","article-title":"The relationship of actigraph accelerometer cut-points for estimating physical activity with selected health outcomes: results from NHANES 2003\u201306","volume":"83","author":"Loprinzi","year":"2012","journal-title":"Res Q Exerc Sport"},{"issue":"8","key":"10.1016\/j.chest.2020.02.016_bib26","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"2011 Compendium of Physical Activities: a second update of codes and MET values","volume":"43","author":"Ainsworth","year":"2011","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"10.1016\/j.chest.2020.02.016_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/rccm.200210-1245OC","article-title":"Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends","volume":"168","author":"Latsi","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2020.02.016_bib29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00131912","article-title":"Prevalence and prognosis of unclassifiable interstitial lung disease","volume":"42","author":"Ryerson","year":"2013","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220303275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220303275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:59:20Z","timestamp":1762124360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220303275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0012369220303275"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.02.016","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of\u00a0Pulmonary Hypertension Associated With Pulmonary Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}